Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
08/01/14 Sanofi (SNY) Myozyme/Lumizyme for Pompe disease Subscribers Only Subscribers Only     Subscribers Only
08/01/14 Boehringer Jardiance for Diabetes Mellitus, Type II Subscribers Only Subscribers Only     Subscribers Only
08/01/14 Biota (BOTA) Laninamivir for Influenza therapeutics (excluding vaccines) Subscribers Only Subscribers Only     Subscribers Only
07/31/14 Baxter (BAX) HyQvia for Primary Immunodeficiencies Subscribers Only Subscribers Only     Subscribers Only
07/31/14 Novartis (NVS) Arzerra for Chronic Lymphocytic Leukemia (CLL)/Small Cell Lymphocytic Lymphoma (SLL) - NHL Subscribers Only Subscribers Only     Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
08/04/14 Subscribers Only Subscribers Only Company - Earnings Announcement
08/04/14 Subscribers Only Subscribers Only Company - Earnings Announcement
08/04/14 Subscribers Only Subscribers Only Company - Earnings Announcement
08/04/14 Subscribers Only Subscribers Only Company - Earnings Announcement
08/04/14 Subscribers Only Subscribers Only Company - Earnings Announcement